Kasvu Therapeutics
Kasvu Therapeutics develops small-molecule treatments intended to stimulate neuroplasticity without the hallucinogenic effects associated with psychedelic drugs.
€30MSeries A
ParticipantActivity from announced rounds
Kasvu Therapeutics develops small-molecule treatments intended to stimulate neuroplasticity without the hallucinogenic effects associated with psychedelic drugs.
Anferra develops a recycling process that turns steel grinding waste into iron chloride for water treatment, hydrogen and recoverable alloy materials.
AlixLabs develops atomic-layer etching processes and equipment for semiconductor manufacturers making smaller, more densely packed chip features.